Jennifer Harcourt to Humans
This is a "connection" page, showing publications Jennifer Harcourt has written about Humans.
Connection Strength
0.059
-
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States. Emerg Infect Dis. 2020 06; 26(6):1266-1273.
Score: 0.007
-
Establishing a liquid-covered culture of polarized human airway epithelial Calu-3 cells to study host cell response to respiratory pathogens in vitro. J Vis Exp. 2013 Feb 07; (72).
Score: 0.004
-
Evaluating the Presence of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From Nursing Home Residents With Persistently Positive Reverse Transcription Polymerase Chain Reaction (RT-PCR) Results. Clin Infect Dis. 2022 02 11; 74(3):525-528.
Score: 0.002
-
Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing. J Infect Dis. 2022 01 18; 225(2):229-237.
Score: 0.002
-
Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing Site. J Pediatric Infect Dis Soc. 2021 Dec 31; 10(12):1052-1061.
Score: 0.002
-
Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020. Clin Infect Dis. 2021 12 16; 73(12):2217-2225.
Score: 0.002
-
Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing. Clin Infect Dis. 2021 09 15; 73(6):e1348-e1355.
Score: 0.002
-
Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States. J Infect Dis. 2021 09 01; 224(5):771-776.
Score: 0.002
-
Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students. Emerg Infect Dis. 2021; 27(10):2662-2665.
Score: 0.002
-
Detection of SARS-CoV-2 on Surfaces in Households of Persons with COVID-19. Int J Environ Res Public Health. 2021 08 02; 18(15).
Score: 0.002
-
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 on Self-Collected Saliva or Anterior Nasal Specimens Compared With Healthcare Personnel-Collected Nasopharyngeal Specimens. Clin Infect Dis. 2021 07 15; 73(Suppl 1):S65-S73.
Score: 0.002
-
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020. Clin Infect Dis. 2021 06 15; 72(12):e1004-e1009.
Score: 0.002
-
Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies. Sci Rep. 2021 05 06; 11(1):9682.
Score: 0.002
-
Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses. Emerg Infect Dis. 2021 05; 27(5):1380-1392.
Score: 0.002
-
Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 22; 70(3):100-105.
Score: 0.002
-
Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May-June, 2020. Emerg Infect Dis. 2021 Feb; 27(2):421-429.
Score: 0.002
-
Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 01; 69(5152):1642-1647.
Score: 0.002
-
Characteristics and Timing of Initial Virus Shedding in Severe Acute Respiratory Syndrome Coronavirus 2, Utah, USA. Emerg Infect Dis. 2021 Feb; 27(2):352-359.
Score: 0.002
-
US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020 Aug; 26(8).
Score: 0.002
-
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med. 2020 05 28; 382(22):2081-2090.
Score: 0.002
-
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020 04 29; 12(541).
Score: 0.002
-
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 04 16; 382(16):1564-1567.
Score: 0.002
-
Serologic Follow-up of Middle East Respiratory Syndrome Coronavirus Cases and Contacts-Abu Dhabi, United Arab Emirates. Clin Infect Dis. 2019 01 18; 68(3):409-418.
Score: 0.002
-
Conveyance Contact Investigation for Imported Middle East Respiratory Syndrome Cases, United States, May 2014. Emerg Infect Dis. 2017 09; 23(9):1585-1589.
Score: 0.001
-
Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017. MMWR Morb Mortal Wkly Rep. 2017 Jul 28; 66(29):781-793.
Score: 0.001
-
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2016 10; 22(10):1824-6.
Score: 0.001
-
RSV Growth and Quantification by Microtitration and qRT-PCR Assays. Methods Mol Biol. 2016; 1442:13-32.
Score: 0.001
-
Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014 Nov 01; 59(9):1225-33.
Score: 0.001
-
Coronavirus antibodies in bat biologists. Emerg Infect Dis. 2008 Jun; 14(6):999-1000.
Score: 0.001
-
Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins. Clin Vaccine Immunol. 2007 Mar; 14(3):331-3.
Score: 0.001
-
Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. J Virol Methods. 2005 Sep; 128(1-2):21-8.
Score: 0.001